Category: VascularSyndicate content

Vascular

Admedus releases new CardioCel scaffold in U.S.

May 18, 2015 by Fink Densford

Admedus announces the U.S. launch of a new version of its CardioCel regenerative bioscaffold for vascular repair.

Admedus releases new CardioCel scaffold in U.S.

Admedus (ASX:AHZ) announced the U.S. launch of a new CardioCel bioscaffold designed for vascular repairs.

AngioDynamics wants court to enforce $160m Biolitec judgment

April 13, 2015 by Brad Perriello

AngioDynamics wants a federal court to enforce its $160 million judgment against erstwhile partner Biolitec AG and its CEO over an alleged scheme to evade U.S legal jurisdiction.

AngioDynamics wants court to enforce $75m Biolitec judgment

Stealthy Saphena Medical raises $1.3m

March 30, 2015 by Mark Hollmer

Saphena Medical, which is developing a device to harvest veins for coronary artery bypass grafting, is almost halfway toward raising $3 million in new funding.

Stealthy Saphena Medical raises $1.3m

Stealthy Saphena Medical reported raising close to half of a $3 million planned offering toward development of a device designed to harvest veins for coronary artery bypass grafting.

The West Bridgewater, Mass.-based startup disclosed in a recent SEC filing that it has pulled in nearly $1.27 million so far, through the sale of Series B preferred stock.

Appeals court upholds AngioDynamics injunction, $160m penalty against Biolitec

March 12, 2015 by Brad Perriello

A federal appeals court issues a pair of wins to AngioDynamics in its long-running dispute with former partner Biolitec, including some $160 million in fines, but remands a portion of the case to cap the penalties.

Appeals court upholds AngioDynamics injunction, contempt penalty for Biolitec

Veniti raises $17m for Vici venous stent

March 10, 2015 by Mark Hollmer

Veniti, armed with $17 million in new financing, moves forward with more testing and an international launch of its Vici venous stent system.

Veniti raises $17m for Vici venous stent

Veniti said it nailed down a $17 million Series C financing it plans to use to advance testing and commercialization of its Vici venous stent system.

AngioDynamics looks to get in on EmboMedics

March 2, 2015 by Brad Perriello

AngioDynamics inks a deal to invest in EmboMedics and its ResoSphere resorbable embolic microsphere technology, with a possible acquisition on the table.

AngioDynamics looks to get in on EmboMedics

Covidien recalls Trellis clot-busting devices on labeling snafu

February 11, 2015 by Brad Perriello

A labeling miscue prompts Covidien to recall 2 models of its Trellis clot-busting infusion device.

Covidien recalls Trellis clot-busting devices on labeling snafu

UPDATED Feb. 12, 2015, with new information from Medtronic.